Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 1, 2024
March 5, 2024
015fb9da-fe66-4838-a5f4-d2dd19dde786
Related Documents
Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices
Guidance DocumentDecember 30, 2024Center for Drug Evaluation and Research
Use of Data Monitoring Committees in Clinical Trials
Guidance DocumentFebruary 13, 2024Center for Drug Evaluation and Research
Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers
Guidance DocumentJuly 8, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.